Behind the science
Addressing Long-Standing Barriers to Adult Immunization
With our COiMMUNITY Initiative, we are designing a more systematic, collaborative and equitable approach to help increase vaccination rates.
Press releases
- Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia
- GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations
- GSK announces AREXVY, its respiratory syncytial virus (RSV) vaccine, is now available at all major US retail pharmacies
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
GSK Global links
Visit our Global site for additional features
